Preparation
| Indication | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Form | 10mg/mL ampoule | ||||||||||||
| Reconstitution | Already in solution | ||||||||||||
| Compatibility | G5 or NS | ||||||||||||
| Administration: |
IV injection
In an emergency, give 500mcg - 1000mcg (1-2ml) bolus slowly over 2-5 IV infusion
IV infusion Administer via an infusion pump at a rate up to 10mg/hour (20mL/hour of 500microgram/mL). If a central venous access device is unavailable, administer via a large peripheral vein monitoring insertion site. Resite cannula at first signs of inflammation. After discontinuation, flush the peripheral cannula with sodium chloride 0.9% at the same rate the medicine was infused to avoid an unintentional 'bolus' dose. Discard the IV administration set administration set before flushing the cannula. Peripheral cannula: Flush if it is to remain in situ. Central venous access device: Aspirate the cannula contents before flushing. |
||||||||||||
| Monitoring | Monitor BP, HR, ECG, CVP, drowsiness, UO, K+, lactate | ||||||||||||
| Extravasation | This medicine has a low pH and may cause venous irritation and tissue damage in cases of extravasation | ||||||||||||
| Additional |
|
||||||||||||
| Information relates to Metaraminol manufactured by Torbay & South Devon NHS Foundation Trust | |||||||||||||